Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Support Care Cancer. 2015 Nov 5;24(5):2059–2066. doi: 10.1007/s00520-015-2996-y

Table 1.

Descriptive statistics for the two fatigue outcomes. N=Sample sixe for complete data only. P-values are associated with testing whether the mean change is statistically different than zero. LCB95 and UCB95 are the lower and upper 95% confidence limits, respectively. These results used multiple imputation.

BFI Total
FACIT-Fatigue
Arm N Mean Std.
Error
P-value LCB9
5
UCB95 Mean Std.
Error
P-value LCB9
5
UCB95
CBT&Placebo
Pre 24 3.37 0.44 2.44 4.29 31.63 2.35 26.75 36.50
Post 18 1.88 0.36 1.13 2.63 40.86 1.92 36.85 44.88
Change 18 −1.48 0.36 0.0005 −2.22 −0.74 9.24 1.75 <0.0001 5.57 12.90

CBT & Drug
Pre 23 3.41 0.47 2.43 4.39 33.01 2.37 28.06 37.96
Post 17 1.31 0.34 0.61 2.02 43.50 2.04 39.21 47.80
Change 17 −2.10 0.37 <0.0001 −2.88 −1.32 10.50 1.94 <0.0001 6.40 14.59

Drug
Pre 24 3.36 0.37 2.58 4.14 32.86 1.94 28.82 36.90
Post 15 2.77 0.40 1.92 3.63 33.24 2.47 28.00 38.47
Change 15 −0.59 0.38 0.1421 −1.39 0.22 0.37 2.10 0.8609 −4.12 4.87

Placebo
Pre 24 4.41 0.48 3.41 5.40 29.13 2.52 23.90 34.35
Post 17 2.97 0.46 2.01 3.94 35.02 2.53 29.74 40.29
Change 17 −1.43 0.35 0.0007 −2.17 −0.70 5.89 1.56 0.0015 2.60 9.19